Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» XP23829
XP23829
Xenoport to seek partner to develop drug; CEO steps down
Yahoo/Reuters
Fri, 10/2/15 - 09:15 am
XenoPort
R&D
Pharma CEOs
XP23829
This Biotech Is Headed For A Steep Drop
Yahoo/Street Authority
Tue, 09/22/15 - 09:35 am
XenoPort
XP23829
What in the World Happened to XenoPort?
Barron's
Tue, 09/15/15 - 03:15 pm
XenoPort
psoriasis
XP23829
XenoPort's psoriasis drug found effective; shares jump
Yahoo/Reuters
Tue, 09/15/15 - 08:54 am
XenoPort
psoriasis
XP23829
5 Big FDA Decisions Expected in September
24/7 Wall St
Sun, 08/30/15 - 02:08 pm
FDA
rolapitant
OPKO Health
Tesaro
Zosano
ZP-Glucagon
XenoPort
XP23829
Apricus Biosciences
RayVa
Xenoport, Questcor, and NuVasive Could Be Big Movers Today
Motley Fool
Wed, 10/30/13 - 09:34 am
XenoPort
Questcor
NuVasive
XP23829
Pain Therapeutics
Horizant
XenoPort to continue development of XP23829 after Phase 1 results
Yahoo/Fly on the Wall
Mon, 09/9/13 - 05:18 pm
XenoPort
XP23829
psoriasis
multiple sclerosis
XenoPort's CEO Hosts XenoPort XP23829 Clinical Trial Results Call (Transcript)
Seeking Alpha
Sat, 10/6/12 - 11:36 am
XenoPort
XP23829
multiple sclerosis
psoriasis